Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
Yao-Te TsaiWen-Cheng ChenChih-Yen ChienCheng-Ming HsuYi-Chan LeeMing-Shao TsaiMeng-Hung LinChia-Hsuan LaiKai-Ping ChangPublished in: World journal of surgical oncology (2020)
In patients with advanced HPSCC, PS was significantly associated with better prognosis than CCRT. PS could be a favorable primary treatment modality for the management of patients with stage IVA HPSCC, particularly those aged ≥ 65 years and with T4 and N2 classification.